ACE393
ACE393-103
Phase 2 mab active
Quick answer
ACE393 for Campylobacter Infection is a Phase 2 program (mab) at Fulcrum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fulcrum Therapeutics
- Indication
- Campylobacter Infection
- Phase
- Phase 2
- Modality
- mab
- Status
- active